# GRP

## Overview
The gastrin-releasing peptide (GRP) gene encodes a neuropeptide that is part of the bombesin-like family of peptides, which are known for their role in various physiological processes. The GRP protein functions primarily as a regulatory molecule, influencing exocrine and endocrine secretions, gastrointestinal motility, and the modulation of pain perception and stress responses. It exerts its effects by binding to the gastrin-releasing peptide receptor (GRPR), a G protein-coupled receptor expressed in multiple tissues, including the gastrointestinal tract and nervous system (Czepielewski2011Gastrinreleasing; Kim2017Gastrinreleasing). Beyond its physiological roles, GRP is implicated in pathological conditions, particularly in cancer, where it acts as a mitogen and is involved in tumor growth and progression (Patel2006Gastrinreleasing). The clinical significance of GRP is underscored by ongoing research into therapeutic strategies targeting GRP and its receptors for cancer treatment and diagnosis (Patel2006Gastrinreleasing).

## Function
Gastrin-releasing peptide (GRP) is a neuropeptide that plays a significant role in various physiological processes in healthy human cells. It is primarily involved in the regulation of exocrine and endocrine secretions, gastrointestinal motility, and modulation of pain perception and stress responses (Kim2017Gastrinreleasing). GRP functions as a regulatory molecule by binding to the gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor family, which is expressed in various tissues, including the gastrointestinal tract, nervous system, and vascular endothelial cells (Kim2017Gastrinreleasing; Czepielewski2011Gastrinreleasing).

In the gastrointestinal tract, GRP stimulates the release of gastrin, which in turn promotes gastric acid secretion, aiding in digestion (Spindel1984Cloning). GRP also acts as a growth factor and morphogen, influencing cell growth and differentiation in certain tissues (Kim2017Gastrinreleasing). In the nervous system, GRP is involved in controlling circadian rhythms, anxiety, and stress, and it modulates memory processes (Czepielewski2011Gastrinreleasing).

GRP also plays a role in the immune response by acting as a chemoattractant for neutrophils, promoting their migration and recruitment, which is crucial for inflammatory responses (Czepielewski2011Gastrinreleasing). This highlights its function as an endogenous inflammatory mediator, contributing to the regulation of immune cell activity (Kim2017Gastrinreleasing).

## Clinical Significance
Alterations in the expression of the gastrin-releasing peptide (GRP) gene have been implicated in various cancers. GRP acts as a mitogen, promoting cell proliferation in several cancer types, including colorectal, small cell lung cancer (SCLC), prostate, and breast cancers (Patel2006Gastrinreleasing). In colorectal cancer, GRP and its receptor (GRP-R) are co-expressed in well-differentiated tumors, suggesting a role in maintaining tumor differentiation. However, GRP-R expression is higher in poorly differentiated tumors and those with lymphatic invasion, indicating its involvement in cancer progression (Patel2006Gastrinreleasing).

In SCLC, GRP is considered an autocrine growth factor, with elevated circulating proGRP levels serving as a potential diagnostic and prognostic marker (Patel2006Gastrinreleasing). GRP expression is also noted in prostate cancer, where it is associated with tumor growth and progression (Patel2006Gastrinreleasing). In breast cancer, GRP receptors are frequently found, suggesting a role in tumor development (Patel2006Gastrinreleasing).

Therapeutic strategies targeting GRP and its receptors are being explored, including the use of GRP antagonists and radiolabeled GRP analogues for cancer treatment and diagnosis (Patel2006Gastrinreleasing). These findings underscore the clinical significance of GRP in cancer diagnosis and therapy.


## References


[1. (Patel2006Gastrinreleasing) Oneel Patel, Arthur Shulkes, and Graham S. Baldwin. Gastrin-releasing peptide and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1766(1):23–41, August 2006. URL: http://dx.doi.org/10.1016/j.bbcan.2006.01.003, doi:10.1016/j.bbcan.2006.01.003. This article has 51 citations.](https://doi.org/10.1016/j.bbcan.2006.01.003)

[2. (Kim2017Gastrinreleasing) Mi-Kyoung Kim, Hyun-Joo Park, Yeon Kim, Hyung Joon Kim, Soo-Kyung Bae, and Moon-Kyoung Bae. Gastrin-releasing peptide induces monocyte adhesion to vascular endothelium by upregulating endothelial adhesion molecules. Biochemical and Biophysical Research Communications, 485(2):542–549, April 2017. URL: http://dx.doi.org/10.1016/j.bbrc.2017.01.058, doi:10.1016/j.bbrc.2017.01.058. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2017.01.058)

[3. (Spindel1984Cloning) E R Spindel, W W Chin, J Price, L H Rees, G M Besser, and J F Habener. Cloning and characterization of cdnas encoding human gastrin-releasing peptide. Proceedings of the National Academy of Sciences, 81(18):5699–5703, September 1984. URL: http://dx.doi.org/10.1073/pnas.81.18.5699, doi:10.1073/pnas.81.18.5699. This article has 143 citations.](https://doi.org/10.1073/pnas.81.18.5699)

[4. (Czepielewski2011Gastrinreleasing) Rafael Sanguinetti Czepielewski, Bárbara Nery Porto, Lucas Bortolotto Rizzo, Rafael Roesler, Ana Lúcia Abujamra, Larissa Garcia Pinto, Gilberto Schwartsmann, Fernando de Queiroz Cunha, and Cristina Bonorino. Gastrin-releasing peptide receptor (grpr) mediates chemotaxis in neutrophils. Proceedings of the National Academy of Sciences, 109(2):547–552, December 2011. URL: http://dx.doi.org/10.1073/pnas.1110996109, doi:10.1073/pnas.1110996109. This article has 60 citations.](https://doi.org/10.1073/pnas.1110996109)